MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Quality of life after subthalamic stimulation depends on non-motor symptoms in Parkinson’s disease

    H.S. Dafsari, L. Weiss, M. Silverdale, P. Reddy, A. Rizos, M. Samuel, E. Perrier, J. Evans, K. Ashkan, J.N. Petry-Schmelzer, V. Visser-Vandewalle, A. Antonini, P. Martinez-Martin, K.R. Chaudhuri, L. Timmermann (Cologne, Germany)

    Objective: To investigate non-motor symptoms (NMS) to find contributing factors for quality of life (QoL) outcome after subthalamic nucleus (STN) deep brain stimulation (DBS) in…
  • 2016 International Congress

    Associated and predictive factors of depressive symptoms in patients with Parkinson’s disease

    K. Zhu, J.J. Van Hilten, J. Marinus (Leiden, Netherlands)

    Objective: The aim of this longitudinal study is to examine which variables are associated with depressive symptoms in Parkinson's disease (PD), as well as to…
  • 2016 International Congress

    Clinical and biological predictors of excessive daytime sleepiness in early Parkinson’s disease

    T. Simuni, J. Long, C. Caspell-Garcia, C.S. Coffey, W. Oertel, S. Lasch, K. Marek, On behalf of the PPMI Sleep Working Group (Chicago, IL, USA)

    Objective: To examine longitudinal change in excessive daytime sleepiness (EDS) and to determine clinical and biological variables that predict new onset EDS in the cohort…
  • 2016 International Congress

    Non-motor symptoms in advanced Parkinson’s disease patients treated with levodopa/carbidopa intestinal gel, deep brain stimulation, or continuous subcutaneous apomorphine: A systematic literature review and pooled analysis

    K.R. Chaudhuri, E. Terasawa, Y. Jalundhwala, D. Macaulay, R. Ayyagari, Z.Y. Zhou, T. Marshall, K. Chatamra, A. Yucel, K. Sail (London, United Kingdom)

    Objective: To systematically review literature reporting changes in non-motor symptoms (NMS) among patients with advanced PD (APD) treated with levodopa/carbidopa intestinal gel (LCIG), deep brain…
  • 2016 International Congress

    The impact of a movement disorders specialist on resident knowledge, as measured by the resident in-service training examination (RITE)

    A. Killoran (Morgantown, WV, USA)

    Objective: To determine a movement disorders specialist's impact on resident education, as assessed by the Resident In-Service Training Examination (RITE) scores. Background: Neurology resident knowledge…
  • 2016 International Congress

    Demographic feature and clinical characteristic of patients with Parkinson’s disease in Isfahan, Iran

    M. Salari (Isfahan, Islamic Republic of Iran)

    Objective: To evaluated demographic and clinical characteristic feature of patients with Parkinson's disease in Isfahan city in Iran. Background: Parkinson's disease (PD) is one of…
  • 2016 International Congress

    Ethnic differences in rates of Parkinson’s in New Zealand: A nation-wide prevalence and incidence study

    T.L. Pitcher, D.J. Myall, M.R. MacAskill, J.F. Pearson, C.J. Lacey, J.C. Dalrymple-Alford, T.J. Anderson (Christchurch, New Zealand)

    Objective: To estimate the prevalence and incidence of Parkinson's in New Zealand and to investigate if these measures differ between the major ethnic groups represented…
  • 2016 International Congress

    Predicting poor functional outcome in Parkinson’s disease

    A.D. Macleod, C.E. Counsell (Aberdeen, United Kingdom)

    Objective: We aimed to describe progression to, identify independent prognostic factors for, and develop a valid prognostic model for, dependency and “death or dependency” in…
  • 2016 International Congress

    Falls in Parkinson’s disease : Effects on health related quality of life

    T.H. Farombi, J. Yaria, M.O. Owolabi, A. Ogunniyi (Ibadan, Nigeria)

    Objective: Our aim was to assess the effects of falls in PD patients on HrQoL in PD patients. Background: Health related quality of life (HrQoL)…
  • 2016 International Congress

    Promoting optimal physiotherapy practice worldwide: Role of the Association of Physiotherapists in Parkinson’s disease Europe (APPDE)

    M. Graziano, D. Jones, B. Ramaswamy, F. Lindop (Esch-sur-Alzette, Luxembourg)

    Objective: To illustrate how the APPDE promotes optimal physiotherapy expertise in Europe and the world in the care of people with Parkinson's. Background: The APPDE…
  • « Previous Page
  • 1
  • …
  • 106
  • 107
  • 108
  • 109
  • 110
  • …
  • 207
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley